Lumina Fund Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Lumina Fund Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,000	Closed	-$3.27M	–	51
2016 Q4	$3.27M	Buy	+30,000	New	+$3.34M	0.35%	22
2016 Q3	–	Sell	-3,500	Closed	-$495K	–	56
2016 Q2	$495K	Sell	3,500 -9,200	-72%	-$1.36M	0.04%	39
2016 Q1	$1.66M	Hold	12,700	–	–	0.2%	22
2015 Q4	$1.78M	Sell	12,700 -15,000	-54%	-$2.08M	0.15%	23
2015 Q3	$3.68M	Buy	+27,700	New	+$4.77M	0.28%	19

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Lumina Fund Management's JAZZ Position: Q1 2017 in Review

Lumina Fund Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2017, closing a stake of 30,000 shares — an estimated $3.27M sold.

Lumina Fund Management first reported a position in JAZZ in Q3 2015 and held it in 5 quarters. The position peaked at $3.68M in Q3 2015. 306 funds tracked by Wall St. Rank hold JAZZ as of Q1 2017.

Lumina Fund Management reported no remaining Jazz Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Lumina Fund Management sold 30,000 Jazz Pharmaceuticals shares in Q1 2017, an estimated $3.27M.
Lumina Fund Management first reported a position in Jazz Pharmaceuticals in Q3 2015 and held it in 5 quarters.
Lumina Fund Management's Jazz Pharmaceuticals position peaked at $3.68M in Q3 2015.
306 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2017.

Based on Lumina Fund Management's 13F filing for Q1 2017, filed 12 May 2017.